UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

KEYNOTE-100: Phase 2 trial of pembrolizumab in patients with advanced recurrent ovarian cancer

Matulonis, UA; Chen, M; Puhlmann, M; Shentu, Y; Ledermann, J; (2016) KEYNOTE-100: Phase 2 trial of pembrolizumab in patients with advanced recurrent ovarian cancer. Presented at: 41st Annual Congress of the European-Society-for-Medical-Oncology (ESMO), Copenhagen, DENMARK.

Full text not available from this repository.
Type: Conference item (UNSPECIFIED)
Title: KEYNOTE-100: Phase 2 trial of pembrolizumab in patients with advanced recurrent ovarian cancer
Event: 41st Annual Congress of the European-Society-for-Medical-Oncology (ESMO)
Location: Copenhagen, DENMARK
Dates: 07 October 2016 - 11 October 2016
DOI: 10.1093/annonc/mdw374.47
Keywords: Science & Technology, Life Sciences & Biomedicine, Oncology
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > CRUK Cancer Trials Centre
URI: http://discovery.ucl.ac.uk/id/eprint/10032368
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item